Medicare Enrolled

Dr. Thomas Ardiles, MD

Internal Medicine · Dallas, TX
Speaking/Promotional
7777 FOREST LN, Dallas, TX 75230
6157872050
In practice since 2006 (20 years)
NPI: 1437119278 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ardiles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ardiles? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ardiles

Dr. Thomas Ardiles is an internal medicine specialist in Dallas, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Ardiles received a total of $50,290 from 38 pharmaceutical and/or device companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ardiles is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $50,290 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$50,290
Total received (2018-2024)
Avg $8,382/year across 6 years
Top 2% in TX for internal medicine
38
Companies
197
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$42,737 (85.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,165 (10.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,389 (4.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$27
2023
$121
2021
$11,997
2020
$11,196
2019
$23,388
2018
$3,561

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Grifols USA, LLC
$14,817
Mylan Specialty L.P.
$14,771
AstraZeneca Pharmaceuticals LP
$10,228
Cook Incorporated
$4,742
Grifols Shared Services North America, Inc.
$1,449
Stryker Corporation
$1,000
Cook Medical LLC
$707
Genentech USA, Inc.
$496
GENZYME CORPORATION
$341
Boehringer Ingelheim Pharmaceuticals, Inc.
$199
Regeneron Healthcare Solutions, Inc.
$158
Abbott Laboratories
$132
ABIOMED
$125
Boston Scientific Corporation
$112
Haemonetics Corporation
$110
Genentech, Inc.
$104
Allergan Inc.
$93
Philips Electronics North America Corporation
$86
GlaxoSmithKline, LLC.
$82
Sunovion Pharmaceuticals Inc.
$64
La Jolla Pharmaceutical Company
$54
Getinge USA Sales, LLC
$43
Baxter Healthcare
$43
Veran Medical Technologies, Inc.
$39
Octapharma USA, Inc.
$36
Vapotherm Inc
$28
Gilead Sciences, Inc.
$27
United Therapeutics Corporation
$24
Shire North American Group Inc
$23
Actelion Pharmaceuticals US, Inc.
$21
Astellas Pharma US Inc
$21
Advanced Respiratory, Inc
$20
Electromed, Inc.
$19
Merck Sharp & Dohme Corporation
$18
Sandoz Inc.
$16
Circassia Pharmaceuticals Inc
$16
Novartis Pharmaceuticals Corporation
$15
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 79.2% of total payments
Associated products mentioned in payments ›
ALAIR · AMBISOME · ASTHMA - DISEASE · AVYCAZ · BALFAXAR · Betaseron · COOK MEDICAL PERCUTANEOUS TRACHEOSTOMY · Cardiohelp · CentriMag · Cook Medical Ciaglia Blue Rhino · DUPIXENT · Esbriet · FASENRA · GENERAL BRONCHIAL THERMOPLASTY · GIAPREZA · GLASSIA · GLIDE SYSTEM · Hillrom - Vest System Model 105 Home Care · Impella · LONHALA MAGNAIR · NIOX VERO · NUCALA · OFEV · OPSUMIT MACITENTAN · Perforomist · Precision Flow · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · S&RC Und · SMARTVEST · STIOLTO RESPIMAT · SYMBICORT · Spin · TEG · TREPROSTINIL · The Vest System Model 105 Home Care · UTIBRON NEOHALER · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for internal medicine in TX.

Looking for an internal medicine specialist in Dallas?
Compare internal medicine physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,226
Per 100K population
85.5
County median income
$74,149
Nearest hospital
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ardiles is an internal medicine specialist, with speaking/promotional industry engagement in the top 2% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ardiles receive payments from pharmaceutical companies?
Yes. Dr. Ardiles received a total of $50,290 from 38 companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Ardiles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Internal Medicine Physicians in Dallas
Browse internal medicine physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Grifols USA, LLC Payments to Doctors
See all physicians who received payments from Grifols USA, LLC.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →